• Helicobacter pylori Antigen, Feces
  • Alprazolam, Serum 
  • Cyclin-D1 (BCL1) Expression, Immunohistochemistry, Tissue
  • MDM2 Gene Amplification, FISH
  • 18-Hydroxycorticosterone
  • FLT3 (FMS-related Tyrosine Kinase 3) Mutation Analysis, Blood
  • UDP Glucuronosyltransferase 2B15 (UGT2B15) Genotyping
  • Leukocyte Alkaline Phosphatase
  • Strata Select™, EpiSwitch® CiRT for Immunotherapy Management
  • Epidermal Nerve Fiber Density (ENFD)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

References
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...